Log in

Relevant bibliographies by topics / Pulmonary Pathophysiology / Books

To see the other types of publications on this topic, follow the link: Pulmonary Pathophysiology.

Books on the topic 'Pulmonary Pathophysiology'

Author: Grafiati

Published: 4 June 2021

Last updated: 19 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Pulmonary Pathophysiology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Pulmonary pathophysiology. Philadelphia: Lippincott, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pulmonary pathophysiology: The essentials. 7th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

B, West John, ed. Pulmonary pathophysiology--the essentials. 4th ed. Baltimore: Williams & Wilkins, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

West, John B. (John Burnard), ed. Pulmonary pathophysiology: The essentials. 8th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Pulmonary pathophysiology: The essentials. 3rd ed. Baltimore: Williams & Wilkins, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

B, West John, ed. Pulmonary pathophysiology--the essentials. 5th ed. Baltimore, Md: Williams & Wilkins, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pulmonary pathophysiology: A clinical approach. 3rd ed. New York: McGraw-Hill Medical, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Workshop on "Chronic Pulmonary Hyperinflation" (1988 Montescano, Italy). Chronic pulmonary hyperinflation. London: Springer-Verlag, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Pulmonary circulation: Diseases and their treatment. 3rd ed. London: Hodder Arnold, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bittar, E. Edward. Pulmonary biology in health and disease. Edited by Springer-Verlag. New York: Springer, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Belvisi, Maria G., and Jane A. Mitchell, eds. Nitric Oxide in Pulmonary Processes: Role in Physiology and Pathophysiology of Lung Disease. Basel: Birkhäuser Basel, 2000. http://dx.doi.org/10.1007/978-3-0348-8474-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Workshop "Respiratory Muscles in C.O.P.D." (1986 Montescano, Italy). Respiratory muscles in chronic obstructive pulmonary disease. London: Springer-Verlag, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Yuan, Jason X.-J., 1963- and Ward Jeremy P. T, eds. Membrane receptors, channels, and transporters in pulmonary circulation. Dordrecht: Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Principles of exercise testing and interpretation: Including pathophysiology and clinical applications. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Die Wirkung skelettmuskulärer Aktivität auf den Atemwiderstand: Eine psychologische Untersuchung mit gesunden und asthmatischen Personen. Frankfurt am Main: P. Lang, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

West, John B. Pulmonary Pathophysiology: The Essentials (Pulmonary Pathophysiology). 7th ed. Lippincott Williams & Wilkins, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Pulmonary Pathophysiology: The Essentials (Pulmonary Pathophysiology). 6th ed. Lippincott Williams & Wilkins, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Juzar, Ali, Summer Warren R, and Levitzky Michael G, eds. Pulmonary pathophysiology. New York: McGraw-Hill, Health Professions Division, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Juzar, Ali, Summer Warren R, and Levitzky Michael G, eds. Pulmonary pathophysiology. 2nd ed. New York: Lange Medical Books/McGraw-Hill, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Ali, Juzar. Pulmonary Pathophysiology. McGraw-Hill Professional, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Ali, Juzar. Pulmonary Pathophysiology. McGraw-Hill Professional, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Pulmonary Pathophysiology (The Pathophysiology Series). Fence Creek Publishing, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

West's Pulmonary Pathophysiology. Lippincott Williams & Wilkins, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

West, John Jr. Pulmonary Pathophysiology: The Essentials. 3rd ed. Williams & Wilkins, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Kenneth, Weir E., and Reeves John T, eds. Pulmonary vascular physiology and pathophysiology. New York: Dekker, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ali, Juzar, Warren G. Summer, and Michael G. Levitzky. Pulmonary Pathophysiology (Lange Physiology Series). McGraw-Hill Medical, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Ali, Juzar, Warren G. Summer, and Michael G. Levitzky. Pulmonary Pathophysiology (Lange Physiology Series). 2nd ed. McGraw-Hill Medical, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

J, Whipp Brian, and Wasserman Karlman, eds. Exercise: Pulmonary physiology and pathophysiology. New York: M. Dekker, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

1925-, Morpurgo M., ed. Pathophysiology and treatment of pulmonary circulation. London: Springer-Verlag, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Price, Laura, and S. John Wort. Pathophysiology and causes of pulmonary hypertension. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0168.

Full text

Abstract:

Pulmonary hypertension (PH) in the setting of critical illness may reflect the acute syndrome itself (such as acute massive pulmonary embolism or acute lung injury), and/or pre-existing ‘chronic’ causes of PH. To compound this, iatrogenic factors may also contribute to PH including the effects of positive pressure ventilation and certain vasoactive drugs. The presence of PH, especially when complicated by resulting right ventricular (RV) dysfunction and failure, is a poor prognostic feature in all settings. This chapter reviews the pathophysiology of acute PH in critical illness, and pre-existing chronic causes of PH, including acute decompensation in patients with pre-existing pulmonary arterial hypertension.

APA, Harvard, Vancouver, ISO, and other styles

31

Singer, Mervyn. Pathophysiology and causes of pulmonary embolism. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0170.

Full text

Abstract:

Pulmonary embolus is predominantly due to thrombus breaking off from deep veins or from within the right heart, lodging within large or small vessels within the pulmonary vasculature, causing a variable degree of clinical features ranging from asymptomatic through to shock and cardiac arrest. Non-thrombotic causes include air or fat embolism. Outcome is predicated by the degree of right ventricular dysfunction. There are multiple risk factors including surgery, arrhythmias, prolonged immobility, venous stasis, pregnancy and an underlying pro-thrombotic tendency, either congenital or acquired. Numerous risk stratification scores have been developed derived from clinical features, imaging findings and biochemical markers of right ventricular strain and myocardial damage.

APA, Harvard, Vancouver, ISO, and other styles

32

F, Voelkel Norbert, and Rounds Sharon 1946-, eds. The pulmonary endothelium. Chichester, West Sussex: John Wiley & Sons, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

A, Bray Michael, and Anderson Wayne H, eds. Mediators of pulmonary inflammation. New York: M. Dekker, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

R, Filbin Michael, ed. Blueprints notes & cases, pathophysiology: Pulmonary, gastrointestinal, and rheumatology. Malden, Mass: Blackwell Pub., 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

S, Zander Dani, and Farver Carol F, eds. Pulmonary pathology. Philadelphia: Churchill Livingstone/Elsevier, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Grassino, A. Chronic Pulmonary Hyperinflation. Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Grassino, A., C. Rampulla, and R. Corsico. Chronic Pulmonary Hyperinflation. Springer, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

P, Lynch Joseph, and DeRemee Richard A. 1933-, eds. Immunologically mediated pulmonary diseases. Philadelphia: Lippincott, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Pulmonary Physiology and Pathophysiology: An Integrated, Case-Based Approach. Lippincott Williams & Wilkins, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

A, Parent Richard, ed. Treatise on pulmonary toxicology. Boca Raton: CRC Press, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

1926-, Grassi Carlo, and Workshop "Update in Biochemistry of Pulmonary Emphysema" (1990 : Pavia, Italy), eds. Biochemistry of pulmonary emphysema. London: Springer-Verlag, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Blanchard-Loeb. Heart Failure and Pulmonary Edema: Pathophysiology for Nurses Video Series. Delmar Learning, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Vergnaud, Sophie, David Dobarro, and John Wort. Pulmonary vasculature. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0017.

Full text

Abstract:

A 16-year-old girl with a diagnosis of diffuse cutaneous systemic sclerosis is referred to a specialist pulmonary hypertension centre with a history of progressive breathlessness, reduced exercise tolerance, and raised pulmonary pressures on transthoracic echocardiogram. She is found to have pulmonary arterial hypertension on right cardiac catheterization and is started on sildenafil, a phosphodiesterase-5 inhibitor, which stabilizes her condition. An endothelin receptor antagonist is added, which provides some initial symptomatic improvement. She continues to deteriorate over a period of 5 years, ultimately requiring intravenous prostanoids, the only treatment to provide a real symptomatic and haemodynamic improvement. This chapter explores the physiology and pathophysiology of pulmonary arterial hypertension, its classification, the means of investigation and diagnosis, who to refer to specialist centres, and the concepts behind current and future treatment strategies.

APA, Harvard, Vancouver, ISO, and other styles

44

Textbook of pulmonary medicine. 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Tombetti, Enrico, and Justin C. Mason. Pathophysiology of vasculitis. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755777.003.0017.

Full text

Abstract:

Vasculitis represents a spectrum of disorders that are often divided on the basis of the predominant vessel size affected into large-, medium- and small-vessel vasculitides. This chapter will focus on the pathogenesis of the anti-neutrophil cytoplasmic antibody (ANCA)-associated medium- and small-vessel vasculitides (AAV), and large-vessel vasculitis, Takayasu arteritis, and giant cell arteritis. Underlying pathogenic mechanisms in vasculitis remain to be fully understood. In particular, the initiating event(s) are not known. A combination of infectious or other environmental triggers on a susceptible genetic background is currently favoured. In addition to the vessel size affected, the mechanisms of vascular injury vary. Moreover, extravascular granulomatosis may play an important role in disease manifestations. The innate and adaptive immune systems contribute to its pathogenesis. Although pathogenic antibodies have not been identified in large-vessel vasculitis, ANCA are directly implicated in small- and medium-vessel AAV. Disease manifestations are varied and diverse and may include arterial stenosis or aneurysms, glomerulonephritis and renal failure, gastro-intestinal, pulmonary, cutaneous, and neurological complications, visual disturbance, deafness, and nasal bridge collapse. Life-threatening cardiovascular disease is also seen, with myocarditis, pericarditis, valvular heart disease, thrombosis, systemic and pulmonary arterial hypertension, and accelerated coronary heart disease all reported. Despite this, the prognosis for patients with vasculitis has improved significantly in recent decades. Further understanding of the pathogenesis of vasculitis will lead to the discovery of further therapeutic targets and novel, safer biologic therapies.

APA, Harvard, Vancouver, ISO, and other styles

46

Denham, Ward, Dahan Albert, and Teppema Luc J, eds. Pharmacology and pathophysiology of the control of breathing. Boca Raton, FL: Taylor & Francis, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Pulmonary Vascular Physiology and Pathophysiology. Informa Healthcare, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Modell, Jerome H., and Sean Kiley. Pathophysiology and management of drowning. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0348.

Full text

Abstract:

Drowning is a process beginning with airway submergence under a fluid medium, progressing to aspiration, and ultimately death in the absence of intervention. Aspiration of both fresh- and saltwater can cause pulmonary oedema, decreased compliance, intrapulmonary shunting, and severe hypoxia. Devastating neurological injury resulting from prolonged cerebral hypoxia is proportional to the duration of submersion and delay in effective resuscitation and oxygenation. Victims presenting to the emergency department awake and alert, or even stuporous, are likely to have a good neurological outcome with follow-up intensive care. Those presenting comatose are much more likely to have severe neurological deficits. Keys to survival are: timely rescue from the water, immediate initiation of aggressive supportive care regarding airway, cardiovascular and pulmonary function, and optimization of tissue oxygenation.

APA, Harvard, Vancouver, ISO, and other styles

49

1952-, Müller B., Wichert P. von, and International Symposium on Lung Surfactant (4th : 1992 : Marburg, Germany), eds. Lung surfactant: Basic research in the pathogenesis of lung disorders. Basel: Karger, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Chronic pulmonary hyperinflation (Current topics in rehabilitation). Bi & Gi, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!